Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

NOTES PAYABLE (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended		9 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Jul. 28, 2020	Nov. 30, 2021	Nov. 30, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount				$ 2,262,388		$ 2,262,388		$ 2,262,388
Interest Expense, Debt				811,000	$ 686,000	2,193,000	$ 2,016,000
Lenders [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount				2,262,000		2,262,000
Insurance Policy [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Prepaid expenses				$ 109,375		$ 109,375		$ 1,093,750
Loan Agreement [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Notes payable		$ 984,375	$ 909,375
Monthly principal and interest payments		$ 111,041	$ 103,112
Monthly loan payments term		nine-month period	nine-month period
Annual interest rate		3.64%	4.89%
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Annual interest rate				11.50%		11.50%
Secured debt	$ 50,000,000			$ 21,190,000		$ 21,190,000
Debt description	The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.
Debt maturity date	Aug. 01, 2024
Debt conversion amount						$ 5,000,000
Debt conversion per share				$ 9.40		$ 9.40
Warrants to purchase shares of common stock, exercised	86,206
Warrant exercisable price per share	$ 6.96
Proceeds from Warrant Exercises	$ 472,000
Proceeds from prepayment and default features	546,000
Debt issuance cost	1,244,000
Final payment	1,190,000			$ 1,190,000		$ 1,190,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-Based Payment Arrangement, Tranche One [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt	20,000,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-based Payment Arrangement, Tranche Two [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt	20,000,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-based Payment Arrangement, Tranche Three [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt	$ 10,000,000
Event of Default - Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Annual interest rate				5.00%		5.00%
Debt maturity date						Aug. 01, 2024